Global Influenza Drugs and Vaccines Market By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent): Analysis By Region, By Country: Opportunities and Forecast (2016-2021) By Product Type- Vaccines, Therapeutics By Therapeutics - Relenza (Zanamivir), Tamiflu (Oseltamivir Phosphate), Rapivab (Peramivir) By Region-North America, Europe, APAC, ROW By Country US, Canada, UK, France, India, China Policy & Regulations Pipeline Analysis 1 May 2017
Global Influenza Drugs and Vaccines Market By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent): Analysis By Region, By Country (2016-2021) Scope of the Study Global Coverage Regional Coverage Country Coverage Segment Coverage Drugs Type Vaccines Type By Drugs - Zanamivir, Oseltamivir Phosphate, Peramivir By Vaccines Trivalent, Quadrivalent Global Coverage Regional Coverage Country Coverage Company Coverage Influenza Market (2011-15) Influenza Market (2016-21) Breakdown-By Product Type Therapeutics (2011-2015) Therapeutics (2016-2021) Vaccines Market (2011-15) Vaccines Market (2016-21) North America Europe Asia Pacific ROW U.S. Canada U.K. France India China Teva Pharmaceutical Industries Ltd. Emergent Biosolutions Sanofi Pasteur, Inc. GlaxoSmithKline Merck & Co., Inc. CSL Limited Astrazeneca Pfizer Serum Institute Of India Pvt. Ltd. Protein Sciences Corporation Breakdown-By Therapeutics Type Relenza (zanamivir) Tamiflu (oseltamivir phosphate) Rapivab (peramivir) Breakdown By Vaccine Type Trivalent Vaccine Quadrivalent Vaccine Influenza Market(2011-15) Influenza Market (2016-21) Influenza Market : By Product Type (2011-15) Influenza Market : By Product Type (2016-21) Anti-Infective Vaccines Market (2011-15) Anti-Infective Vaccines Market (2016-21) Product Benchmarking Policy and Regulatory Landscape Financial Analysis Sales Business Strategy Market Entry Strategy 2
S.No Particulars Page No. 1. Introduction 14 1.1. Research Methodology 14 1.2. Executive Summary 15 1.3. Strategic Recommendation 16 1.3. Product Overview 17 2. Global Influenza Market Overview 21 2.1. Global Influenza Market Size, By Value, Historic, 2011-2015 22 2.2. Global Influenza Market Size, By Value, Forecast, 2016-2021 23 3. Global Influenza Market, Product Analysis 24 3.1. By Product-Actual(2015) 25 3.2. By Product-Forecast(2021) 26 3.3. Global Influenza Therapeutics Market, Historic, 2011-2015 27 3.4. Global Influenza Therapeutics Market,Forecast, 2016-2021 28 3.5. Global Influenza Vaccines Market, Historic, 2011-2015 29 3.6. Global Influenza Vaccines Market, Forecast, 2016-2021 30 3.7. Global Influenza Therapeutics Market, By Drug Type 31 3.7.1. Global Zanamivir Market, Historic, 2011-2015 32 3.7.2. Global Zanamivir Market, Forecast, 2016-2021 33 3.7.3. Global Oseltamivir Phosphate Market, Historic, 2011-2015 35 3.7.4. Global Oseltamivir Phosphate Market, Forecast, 2016-2021 36 3.7.5. Global Peramivir Market, Forecast, 2016-2021 38 3.8. Global Influenza Vaccines Market, By Vaccine Type 39 3.8.1. Global Trivalent Vaccines Market, Historic, 2011-2015 40 3.8.2. Global Trivalent Vaccines Market, Forecast, 2016-2021 41 3.8.3. Global Quadrivalent Vaccines Market, Historic, 2011-2015 43 3.8.4. Global Quadrivalent Vaccines Market, Forecast, 2016-2021 44 (c) AZOTH Analytics 3
S.No Particulars Page No. 4. Global Influenza Vaccines & Drugs - Pipeline Analysis 46 5. Global Influenza Market, By Region 48 5.1. By Region-Actual(2015) 49 5.2. By Region-Actual(2021) 50 6. North America Influenza Market Overview 51 6.1. North America Influenza Market Size, By Value, Historic, 2011-2015 52 6.2. North America Influenza Market Size, By Value, Forecast, 2016-2021 53 6.3. North America Influenza Therapeutics Market Size, By Value, Historic, 2011-2015 55 6.4. North America Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 56 6.5. North America Influenza Vaccines Market Size, By Value, Historic 2011-2015 58 6.6. North America Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 59 6.7. North America Influenza Therapeutics: Segment Analysis 60 6.8. North America Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015 61 6.9. North America Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021 62 6.10. North America Influenza Vaccines: Segment Analysis 63 6.11. North America Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015 64 6.12. North America Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021 65 7. United States Influenza Market Overview 66 7.1. United States Influenza Market Size, By Value, Historic, 2011-2015 67 7.2. United States Influenza Market Size, By Value, Forecast, 2016-2021 67 7.3. United States Influenza Therapeutics Market Size, By Value, Historic 2011-2015 69 7.4. United States Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 69 7.5. United States Influenza Vaccines Market Size, By Value, Historic 2011-2015 71 7.6 United States Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 71 7.7. Canada Influenza Market Size, By Value, Historic, 2011-2015 73 7.8. Canada Influenza Market Size, By Value, Forecast, 2016-2021 73 (c) AZOTH Analytics 4
S.No Particulars Page No. 7.9. Canada Influenza Therapeutics Market Size, By Value, Historic 2011-2015 75 7.10. Canada Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 75 7.11. Canada Influenza Vaccines Market Size, By Value, Historic 2011-2015 77 7.12. Canada Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 77 7.13. North America Other Influenza Market Size, By Value, Historic, 2011-2015 79 7.14. North America Other Influenza Market Size, By Value, Forecast, 2016-2021 79 8. Europe Influenza Market Overview 80 8.1. Europe Influenza Market Size, By Value, Historic, 2011-2015 81 8.2. Europe Influenza Market Size, By Value, Forecast, 2016-2021 82 8.3. Europe Influenza Therapeutics Market Size, By Value, Historic, 2011-2015 84 8.4. Europe Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 85 8.5. Europe Influenza Vaccines Market Size, By Value, Historic 2011-2015 87 8.6. Europe Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 88 8.7. Europe Influenza Therapeutics: Segment Analysis 89 8.8. Europe Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015 90 8.9. Europe Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021 91 8.10. Europe Influenza Vaccines: Segment Analysis 92 8.11. Europe Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015 93 8.12. Europe Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021 94 9. United Kingdom Influenza Market Overview 95 9.1. United Kingdom Influenza Market Size, By Value, Historic, 2011-2015 96 9.2. United Kingdom Influenza Market Size, By Value, Forecast, 2016-2021 96 9.3. United Kingdom Influenza Therapeutics Market Size, By Value, Historic 2011-2015 98 9.4. United Kingdom Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 98 9.5. United Kingdom Influenza Vaccines Market Size, By Value, Historic 2011-2015 100 9.6 United Kingdom Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 100 (c) AZOTH Analytics 5
S.No Particulars Page No. 10. France Influenza Market Overview 101 10.1. France Influenza Market Size, By Value, Historic, 2011-2015 102 10.2. France Influenza Market Size, By Value, Forecast, 2016-2021 102 10.3. France Influenza Therapeutics Market Size, By Value, Historic 2011-2015 104 10.4. France Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 104 10.5. France Influenza Vaccines Market Size, By Value, Historic 2011-2015 106 10.6. France Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 106 10.7. Europe Other Influenza Market Size, By Value, Historic, 2011-2015 108 10.8. Europe Other Influenza Market Size, By Value, Forecast, 2016-2021 108 11. APAC Influenza Market Overview 109 11.1. APAC Influenza Market Size, By Value, Historic, 2011-2015 110 11.2. APAC Influenza Market Size, By Value, Forecast, 2016-2021 111 11.3. APAC Influenza Therapeutics Market Size, By Value, Historic, 2011-2015 113 11.4. APAC Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 114 11.5. APAC Influenza Vaccines Market Size, By Value, Historic 2011-2015 116 11.6. APAC Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 117 11.7. APAC Influenza Therapeutics: Segment Analysis 118 11.8. APAC Influenza Therapeutics Market, By Drug Type, Historic, 2011-2015 119 11.9. APAC Influenza Therapeutics Market, By Drug Type, Forecast, 2016-2021 120 11.10. APAC Influenza Vaccines: Segment Analysis 121 11.11. APAC Influenza Vaccines Market, By Vaccine Type, Historic, 2011-2015 122 11.12. APAC Influenza Vaccines Market, By Vaccine Type, Forecast, 2016-2021 123 (c) AZOTH Analytics 6
S.No Particulars Page No. 12. India Influenza Market Overview 124 12.1. India Influenza Market Size, By Value, Historic, 2011-2015 125 12.2. India Influenza Market Size, By Value, Forecast, 2016-2021 125 12.3. India Influenza Therapeutics Market Size, By Value, Historic 2011-2015 127 12.4. India Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 127 12.5. India Influenza Vaccines Market Size, By Value, Historic 2011-2015 128 12.6. India Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 128 13. China Influenza Market Overview 129 13.1. China Influenza Market Size, By Value, Historic, 2011-2015 130 13.2. China Influenza Market Size, By Value, Forecast, 2016-2021 130 13.3. China Influenza Therapeutics Market Size, By Value, Historic 2011-2015 132 13.4. China Influenza Therapeutics Market Size, By Value, Forecast, 2016-2021 132 13.5. China Influenza Vaccines Market Size, By Value, Historic 2011-2015 134 13.6. China Influenza Vaccines Market Size, By Value, Forecast, 2016-2021 134 13.7. APAC Other Influenza Market Size, By Value, Historic, 2011-2015 136 13.8. APAC Other Influenza Market Size, By Value, Forecast, 2016-2021 136 (c) AZOTH Analytics 7
S.No Particulars Page No. 14. ROW Influenza Market Overview 137 14.1. ROW Influenza Market Size, By Value, Historic, 2011-2015 138 14.2. ROW Influenza Market Size, By Value, Historic, 2016-2021 139 15. Market Dynamics 140 15.1. Drivers 140 15.2. Challenges 145 15.3. Trends 148 16. Company Profiles 153 16.1. GlaxoSmithKline 154 16.2. Sanofi Pasteur, Inc. 155 16.3. CSL Limited 156 16.4. Astrazeneca 157 16.5. Protein Sciences Corporation 158 16.6. Serum Institute Of India Pvt. Ltd. 159 16.7. Emergent Biosolutions 160 16.8. Gilead Sciences 161 16.9. BioCryst Pharmaceuticals.Inc. 162 16.10. Alvogen 163 17. About Us 164 (c) AZOTH Analytics 8
List of Figures Figure No. Figure Title Page No. Figure 1: Figure 2: Global Influenza Market Size, By Value, 2011-2015 (USD Billion) Global Influenza Market Size, By Value, 2016E-2021F (USD Billion) 22 23 Figure 3: Global Influenza Market Size and Share, By Product, 2015 25 Figure 4: Key Drivers 25 Figure 5: Global Influenza Market Size and Share, By Product, 2021F 26 Figure 6: Key Drivers 26 Figure 7: Figure 8: Figure 9: Figure 10: Figure 11: Figure 12: Figure 13: Figure 14: Figure 15: Figure 16: Figure 17: Figure 18: Global Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion) Global Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion) Global Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion) Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) Global Zanamivir Market Size, By Value, 2011-2015 (USD Billion) Global Zanamivir Market Size, By Value, 2016E-2021F (USD Billion) Global Oseltamivir Phosphate Market Size, By Value, 2011-2015 (USD Billion) Global Oseltamivir Phosphate Market Size, By Value, 2016E-2021F (USD Billion) Global Peramivir Market Size, By Value, 2016E-2021F (USD Billion) Global Trivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion) Global Trivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion) Global Quadrivalent Vaccines Market Size, By Value, 2011-2015 (USD Billion) 27 28 29 30 32 33 35 36 38 40 41 43 Figure 19: Global Quadrivalent Vaccines Market Size, By Value, 2016E-2021F (USD Billion 44 9
List of Figures Figure No. Figure Title Page No. Figure 20: Global Influenza Market Size and Share, By Region, 2015 49 Figure 21: Key Drivers 49 Figure 22: Global Influenza Market Size and Share, By Region, 2021F 50 Figure 23: Key Drivers 50 Figure 24: Figure 25: Figure 26: North America Influenza Market Size, By Value, 2011-2015 (USD Billion) North America Influenza Market Size, By Value, 2016E-2021F (USD Billion) North America Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion) 52 53 55 Figure 27: North America Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion) 56 Figure 28: North America Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion) 58 Figure 29: North America Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) 59 Figure 30: North America Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion) 61 Figure 31: Figure 32: Figure 33: Figure 34: Figure 35: Figure 36: North America Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion) North America Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion) North America Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion) US Influenza Market Size, By Value, 2011-2021(USD Billion) US Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) US Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 62 64 65 67 69 71 10
List of Figures Figure No. Figure Title Page No. Figure 37: Figure 38: Figure 39: Figure 40: Figure 41: Figure 42: Figure 43: Figure 44: Figure 45: Figure 46: Figure 47: Figure 48: Figure 49: Figure 50: Figure 51: Figure 52 : Canada Influenza Market Size, By Value, 2011-2021(USD Billion) Canada Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) Canada Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) North America Others Influenza Market Size, By Value, 2011-2021 (USD Billion) Europe Influenza Market Size, By Value, 2011-2015 (USD Billion) Europe Influenza Market Size, By Value, 2016E-2021F (USD Billion) Europe Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion) Europe Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion) Europe Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion) Europe Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) Europe Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion) Europe Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion) Europe Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion) Europe Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion) UK Influenza Market Size, By Value, 2011-2021(USD Billion) UK Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 73 75 77 79 81 82 84 85 87 88 90 91 93 94 96 98 Figure 53 : UK Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 100 11
List of Figures Figure No. Figure Title Page No. Figure 54: Figure 55: Figure 56: Figure 57: Figure 58: Figure 59: Figure 60: Figure 61: Figure 62: Figure 63: Figure 64: Figure 65: Figure 66: Figure 67: Figure 68: Figure 69: Figure 70: France Influenza Market Size, By Value, 2011-2021(USD Billion) France Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) France Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) Europe Others Influenza Market Size, By Value, 2011-2021 (USD Billion) APAC Influenza Market Size, By Value, 2011-2015 (USD Billion) APAC Influenza Market Size, By Value, 2016E-2021F (USD Billion) APAC Influenza Therapeutics Market Size, By Value, 2011-2015 (USD Billion APAC Influenza Therapeutics Market Size, By Value, 2016E-2021F (USD Billion) APAC Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion) APAC Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) APAC Influenza Therapeutics Market: By Product, By Value, 2011-2015 (USD Billion) APAC Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion) APAC Influenza Vaccines Market: By Product Type, By Value, 2011-2015 (USD Billion) APAC Influenza Vaccines Market: By Product, By Value, 2016E-2021F (USD Billion) India Influenza Market Size, By Value, 2011-2021(USD Billion) India Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) India Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 102 104 106 108 110 111 113 114 116 117 119 120 122 123 125 127 128 12
List of Figures Figure No. Figure Title Page No. Figure 71: China Influenza Market Size, By Value, 2011-2021(USD Billion) 130 Figure 72: China Influenza Therapeutics Market Size, By Value, 2011-2021(USD Billion) 132 Figure 73: China Influenza Vaccines Market Size, By Value, 2011-2021(USD Billion) 134 Figure 74: APAC Others Influenza Market Size, By Value, 2011-2021 (USD Billion) 136 Figure 75: ROW Influenza Market Size, By Value, 2011-2015 (USD Million) 138 Figure 76: ROW Influenza Market Size, By Value, 2016E-2021F (USD Million) 139 Table A: Influenza Pipe analysis 46 Table B: Influenza Pipe analysis 47 13
Research Methodology Research Definition The Global Influenza Market Report comprises of the study of various aspects of Drug and Vaccines and forecast until 2021. Global Influenza Market has been segmented on basis of Drugs (Relenza - Zanamivir, Tamiflu - Oseltamivir Phosphate, Rapivab - Peramivir), By Vaccine (Trivalent Vaccine, Quadrivalent Vaccine) Pipeline Analysis, By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, France, UK, China, India) Data Analysis and Interpretation Our historic market trend has been figured out by various paid databases which was further triangulated with inputs and insights from industry experts, companies and stakeholders, through primary research (manufacturers, marketing managers, others). Back-of-the-Envelope calculation for the market estimation has been made through proper understanding of the market as well as future business strategies of the companies operating in the market. Azoth Analytics has conducted quantitative as well as qualitative research to gather market insights such as market sizing, market segmentation, recent trends and developments and competitive landscape. Our team has conducted extensive primary surveys by reaching out industry experts across the value chain of the Global Influenza Market.For Forecasting purpose we have accessed some of the paid databases such as Bloomberg, Reuters, Factiva, Hoovers etc. Companies Contacted: Alvogen, Gilead Science and Bio Cryst 14
Global Influenza Market- Product Analysis Rising number of cases around the globe along with rising awareness regarding the drug have been propelling the market for influenza vaccination. Figure : Global Influenza Market Size and Share, By Product, 2015 Figure : Key Drivers 14.83% Vaccines Xxxx Therapeutics Xxxx Xxxx x 85.17% Xxxx Xxxx Source: Azoth Analytics 15
Global Influenza Vaccines Market Rising affordability of the population along with increasing awareness among them and development of a global vaccine is anticipated to drive the market in the forecast period. Figure : Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion) CAGR: xxx% 2016E 2017F 2018F 2019F 2020F 2021F Source: Azoth Analytics Estimates x x. Xxxx Xxxx 16
North America Influenza Therapeutics Market Figure 31: North America Influenza Therapeutics Market: By Therapeutics Type, By Value, 2016E-2021F (USD Billion) 2016E 2017F 2018F 2019F 2020F 2021F Zanamivir Oseltamivir phosphate Peramivir CAGR 2016E-2021F Zanamivir: x%, Oseltamivir Phosphate: x%, Peramivir: x% Source: Azoth Analytics Estimates Xx Xx Xx Xx xx 17
France Influenza Market Overview France Influenza Market is witnessing growth due to high penetration of vaccines and drugs in this country as compared to other less developed countries. Figure : France Influenza Market Size, By Value, 2011-2021(USD Billion) CAGR: xxx% CAGR: xxx% 2011 2012 2013 2014 2015 2016E 2017F 2018F 2019F 2020F 2021F Source: Azoth Analytics Estimates x. x 18
APAC Others Influenza Market Overview The changed perception of the general population and continuous improvements in the formulations of the vaccines and drugs is leading to the growth of this market. Figure : APAC Others Influenza Market Size, By Value, 2011-2021 (USD Billion) CAGR:xxx% CAGR: xxx% 0.130 0.144 0.159 0.174 0.188 0.22 0.25 0.27 0.30 0.33 0.36 2011 2012 2013 2014 2015 2016E 2017F 2018F 2019F 2020F 2021F Source: Azoth Analytics Estimates x. x x 19
About Azoth Analytics Pvt Ltd. Azoth Analytics is a business research and analytics firm that creates in-depth research reports and provides customized research solutions and consultancy services. Verticals in which Azoth Analytics specializes include healthcare and pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food & beverages and technology. Azoth creates comprehensive and in-depth research reports by recording, interpreting and analyzing information. Strategic market sizing and data dredging techniques include secondary research, and primary research (interviews with management personnel and industry experts). Related Reports: Global Biomaterials Market (By Type, By Application, By Region): Opportunities and Forecasts (2016-2021) - (By Material Type Polymer, Ceramic, Metal; By Application - Orthopaedic, Cardiovascular, Plastic Surgery, Wound Care); By Region-North America, Europe, APAC, ROW; By Country US, UK, Germany, Italy, Japan, China, India; Key Players Strategy, Financial Performance) Global Heart Valve Devices Market: Analysis By Procedure (Replacement & Repair), Replacement Procedure By Technique (Mechanical, Bioprosthetic & TAVR), Repair Procedure By Technique (Surgical, Balloon Valvuloplasty & TMVR), By Region, By Country (2016-2021) -- By Region (North America, Europe, Asia Pacific, Rest of the World), By Country (US, Canada, Germany, France, U.K, China, India, Japan, Brazil, Saudi Arabia) Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics therefore, takes no responsibility for any incorrect information supplied to us by industry experts, manufacturers or users. Azoth does not warranty the completeness of the information and data. Also, analysis provided in the report are meant for customers internal use only and not for general publication or disclosure to third parties. 20